Bixiye
P15-17 Change to Administration of Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2017
Natiijooyinka Raadinta
Soo bandhiga 3231 - 3240 ee natiijooyinka 3688
Bixiye
P51R1-17 Updated: Accountable Care Organization Product and Network Name Changes
Taariikhda uu dhaqangalayo Barnaamijka: Nov 15, 2017
Bixiye
P60-17 2018 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2016
Bixiye
P52-16 DHS Guidelines for Mental Health-Targeted Case Management Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 04, 2016
Bixiye
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Taariikhda uu dhaqangalayo Barnaamijka: Des 20, 2016
Bixiye
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P60-16 New Drug-Related Prior Authorization Criteria with Quanatity Limit for Topical Diclofenac Gel, Fluorourcil Cream, Imquimod Cream and Ingenol Gel
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2016
Bixiye
P39-16 Expansion of Drug-Related Xenazine Prior Authorization Criteria with Quantity Limit to Minnesota Health Care Programs
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2016